ESMO 2022 Conference Coverage
ESMO 2022 on KRYSTAL-1: Updated Efficacy & Safety of Adagrasib With/Without Cetuximab in Advanced CRC Harboring a KRASG12C Mutation
By
ESMO 2022 Conference Coverage
FEATURING
Samuel Klempner
By
ESMO 2022 Conference Coverage
FEATURING
Samuel Klempner
Login to view comments.
Click here to Login
GI